Literature DB >> 15095982

Crystal structure of the catalytic domain of human matrix metalloproteinase 10.

I Bertini1, V Calderone, M Fragai, C Luchinat, S Mangani, B Terni.   

Abstract

The catalytic domain of matrix metalloproteinase-10 (MMP-10) has been expressed in Escherichia coli and its crystal structure solved at 2.1 A resolution. The availability of this structure allowed us to critically examine the small differences existing between the catalytic domains of MMP-3 and MMP-10, which show the highest sequence identity among all MMPs. Furthermore, the binding mode of N-isobutyl-N-[4-methoxyphenylsulfonyl]glycyl hydroxamic acid (NNGH), which is one of the most known commercial inhibitors of MMPs, is described for the first time.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15095982     DOI: 10.1016/j.jmb.2003.12.033

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  15 in total

1.  Conformational variability of matrix metalloproteinases: beyond a single 3D structure.

Authors:  Ivano Bertini; Vito Calderone; Marta Cosenza; Marco Fragai; Yong-Min Lee; Claudio Luchinat; Stefano Mangani; Beatrice Terni; Paola Turano
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-04       Impact factor: 11.205

2.  Matrix metalloproteinases are modifiers of huntingtin proteolysis and toxicity in Huntington's disease.

Authors:  John P Miller; Jennifer Holcomb; Ismael Al-Ramahi; Maria de Haro; Juliette Gafni; Ningzhe Zhang; Eugene Kim; Mario Sanhueza; Cameron Torcassi; Seung Kwak; Juan Botas; Robert E Hughes; Lisa M Ellerby
Journal:  Neuron       Date:  2010-07-29       Impact factor: 17.173

3.  Matrix metalloproteinase-10 (MMP-10) interaction with tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2: binding studies and crystal structure.

Authors:  Jyotica Batra; Jessica Robinson; Alexei S Soares; Alan P Fields; Derek C Radisky; Evette S Radisky
Journal:  J Biol Chem       Date:  2012-03-16       Impact factor: 5.157

4.  Matrix Metalloproteinase 10 Degradomics in Keratinocytes and Epidermal Tissue Identifies Bioactive Substrates With Pleiotropic Functions.

Authors:  Pascal Schlage; Tobias Kockmann; Fabio Sabino; Jayachandran N Kizhakkedathu; Ulrich Auf dem Keller
Journal:  Mol Cell Proteomics       Date:  2015-10-16       Impact factor: 5.911

5.  Spinal matrix metalloproteinase 3 mediates inflammatory hyperalgesia via a tumor necrosis factor-dependent mechanism.

Authors:  C A Christianson; B L Fitzsimmons; J-H Shim; A Agrawal; S M Cohen; X-Y Hua; T L Yaksh
Journal:  Neuroscience       Date:  2011-10-20       Impact factor: 3.590

6.  Discovery of a New Class of Potent MMP Inhibitors by Structure-Based Optimization of the Arylsulfonamide Scaffold.

Authors:  Mattia Mori; Assunta Massaro; Vito Calderone; Marco Fragai; Claudio Luchinat; Alessandro Mordini
Journal:  ACS Med Chem Lett       Date:  2013-05-14       Impact factor: 4.345

7.  Matrix metalloproteinase-inhibitor interaction: the solution structure of the catalytic domain of human matrix metalloproteinase-3 with different inhibitors.

Authors:  Luis A Alcaraz; Lucia Banci; Ivano Bertini; Francesca Cantini; Antonio Donaire; Leonardo Gonnelli
Journal:  J Biol Inorg Chem       Date:  2007-08-21       Impact factor: 3.358

8.  A single step purification for autolytic zinc proteinases.

Authors:  Erin M Wilfong; Ursala Locklear; Eric J Toone
Journal:  Bioorg Med Chem Lett       Date:  2009-11-05       Impact factor: 2.823

9.  Matrix metalloproteinase-10/TIMP-2 structure and analyses define conserved core interactions and diverse exosite interactions in MMP/TIMP complexes.

Authors:  Jyotica Batra; Alexei S Soares; Christine Mehner; Evette S Radisky
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

10.  Activity-dependent shedding of the NMDA receptor glycine binding site by matrix metalloproteinase 3: a PUTATIVE mechanism of postsynaptic plasticity.

Authors:  Thorsten Pauly; Miriam Ratliff; Eweline Pietrowski; Rainer Neugebauer; Andrea Schlicksupp; Joachim Kirsch; Jochen Kuhse
Journal:  PLoS One       Date:  2008-07-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.